Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation


Regulatory News:



Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Edison Investment Research Limited: Regional REIT (RGL): Return to the office gathers momentum
Edison Investment Research Limited: Regional REIT (RGL): Return to the office gathers momentum
Edison Investment Research Limited: Regional REIT (RGL): Return to the office gathers momentum
Marcus & Millichap Hires Head of Eastern Region Practice Lead
Marcus & Millichap Hires Head of Eastern Region Practice Lead


Marcus & Millichap Inc. (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today that Marc

Kohl’s Board of Directors Enters into Three-Week Exclusive Negotiations with Franchise Group
Kohl’s Board of Directors Enters into Three-Week Exclusive Negotiations with Franchise Group


Kohl’s Corporation ("Kohl’s" or the "Company") (NYSE: KSS) announced today that following the receipt of final proposals, the Kohl’s Board of Directors has entered into exclusive negotiations with

VICI Properties Inc. Announces First Transaction With Cabot and Entry Into ‘Destination Golf Experience’ Sector
VICI Properties Inc. Announces First Transaction With Cabot and Entry Into ‘Destination Golf Experience’ Sector


VICI Properties Inc. (NYSE: VICI) (“VICI,” “VICI Properties” or the “Company”), an experiential real estate investment trust, announced today that it has entered into a delayed draw term loan

NGL Energy Partners LP Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results; Guidance for Fiscal 2023
NGL Energy Partners LP Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results; Guidance for Fiscal 2023


NGL Energy Partners LP (NYSE:NGL) (“NGL,” “our,” “we,” or the “Partnership”) today reported its fourth quarter and full year fiscal 2022 results. The Partnership reported a loss from continuing

Membership Collective Group to Participate in Goldman Sachs Travel and Leisure Conference
Membership Collective Group to Participate in Goldman Sachs Travel and Leisure Conference


Membership Collective Group Inc. (NYSE: MCG) a global membership platform of physical and digital spaces that connects a vibrant, diverse, and global group of members, announced that Andrew Carnie

Granite to Develop New Aggregate Operation in Grantsville, Utah
Granite to Develop New Aggregate Operation in Grantsville, Utah


Granite (NYSE:GVA) announced today that it has acquired and will start development on a new aggregate operation near Grantsville, Utah. Located approximately 30 miles west of Salt Lake City on

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced

Piper Sandler Expands DIS Investment Banking with Two Key Hires
Piper Sandler Expands DIS Investment Banking with Two Key Hires


Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of managing director, Steven Hull and vice president Frank Damian to the DIS investment banking

Keysight Enables DEKRA to Validate Mobile Phone E112 Caller Location in Compliance with New Regulation
Keysight Enables DEKRA to Validate Mobile Phone E112 Caller Location in Compliance with New Regulation


Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.


Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling

PJSC Magnitogorsk Iron and Steel Works: MMK notifies on initiation of bondholders’ consent solicitation process
PJSC Magnitogorsk Iron and Steel Works: MMK notifies on initiation of bondholders’ consent solicitation process


MMK notifies on initiation of bondholders’ consent solicitation process 06 JUNE 2022 Magnitogorsk, Russia PJSC Magnitogorsk Iron & Steel Works (MOEX: MAGN; LSE: MMK) notifies on initiation of

ISG Launches Digital Engineering Business to Meet Booming Demand for Data- and Software-Driven Business Models
ISG Launches Digital Engineering Business to Meet Booming Demand for Data- and Software-Driven Business Models


Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced the launch of a digital engineering advisory business to meet booming

ADTRAN, Inc. to Meet with Investors at the Rosenblatt Securities The Age of AI Scaling Technology Summit on June 10, 2022
ADTRAN, Inc. to Meet with Investors at the Rosenblatt Securities The Age of AI Scaling Technology Summit on June 10, 2022


ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation networking solutions, announced today that Adtran representatives will meet with investors at the Rosenblatt Securities The Age

GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older
GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older


GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PRIORIX (Measles, Mumps and Rubella Vaccine, Live) for active immunisation for the prevention of

Fix Price Group Ltd. : Notification of PDMR transaction
Fix Price Group Ltd. : Notification of PDMR transaction
Fix Price Group Ltd. : Notification of PDMR transaction
EPR Properties to Present at Nareit's REITweek: 2022 Investor Conference
EPR Properties to Present at Nareit's REITweek: 2022 Investor Conference


EPR Properties (NYSE:EPR) announced today that its President and CEO Gregory Silvers, will make a presentation regarding the Company at Nareit's REITweek: 2022 Investor Conference in New York, NY

Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented results from the Phase II SUMMIT trial, assessing the efficacy of combined neratinib, fulvestrant, and trastuzumab in

Charles River Laboratories to Participate in Jefferies and William Blair Conferences
Charles River Laboratories to Participate in Jefferies and William Blair Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Healthcare Conference on Wednesday, June 8th, at 10:00 a.m. ET, and at the William

Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research


Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent high-resolution LC/MS for oligonucleotide

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status


Clovis Oncology, Inc. (NASDAQ: CLVS) announced today the first presentation of data from the monotherapy arm of the randomized, Phase 3 ATHENA (GOG-3020/ENGOT-ov45) trial (ATHENA-MONO) as a

Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday


Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with Cooper Kupp, professional football wide receiver and MVP of the “Big Game,” to

CI Global Asset Management Claims Compliance with the Global Investment Performance Standards
CI Global Asset Management Claims Compliance with the Global Investment Performance Standards


CI Global Asset Management (“CI GAM”) announced today that it claims compliance with the Global Investment Performance Standards (“GIPS®”) from CFA Institute.


This press release features

Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022


Agilent Technologies Inc. (NYSE: A) today announced new LC/MS and GC/MS quadrupole mass spectrometers which will be on show at the 70th ASMS Conference on Mass Spectrometry and Allied Topics being